State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.
Every year, millions of people worldwide are affected by a virus that often goes unnoticed –Respiratory Syncytial Virus (RSV). Despite its widespread prevalence, many people remain unaware of what RSV ...
Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...
In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...
Hamilton Health Sciences is issuing a reminder that vaccines for respiratory syncytial virus are available for infants less than a year old after seeing a rise in cases over the holiday season.
The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.